
Vivek Subbiah/X
Apr 28, 2025, 12:17
Vivek Subbiah: Exhilarating discussions on new podcast – Immunoverse
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared a post on X:
“Exhilarating discussions with the amazing Patrick Hwu, Moffitt Cancer Center on his new podcast Immunoverse & Dr. Steven Rosenberg, Chief of the Surgery Branch National Cancer Institute.
Fantastic to meet my great colleague Aung Naing, JIPO Editors.”
More posts featuring Vivek Subbiah.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 21, 2025, 21:13
May 21, 2025, 19:10
May 21, 2025, 18:49
May 21, 2025, 18:11
May 21, 2025, 18:05
May 21, 2025, 18:02